Extensive HLA class I allele promiscuity among viral CTL epitopes-Reference-Cited by-同舟云学术

Extensive HLA class I allele promiscuity among viral CTL epitopes

Published:2007-09 Issue:9 Volume:37 Page:2419-2433
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Frahm Nicole,Yusim Karina,Suscovich Todd J.,Adams Sharon,Sidney John,Hraber Peter,Hewitt Hannah S.,Linde Caitlyn H.,Kavanagh Daniel G.,Woodberry Tonia,Henry Leah M.,Faircloth Kellie,Listgarten Jennifer,Kadie Carl,Jojic Nebojsa,Sango Kaori,Brown Nancy V.,Pae Eunice,Zaman M. Tauheed,Bihl Florian,Khatri Ashok,John Mina,Mallal Simon,Marincola Francesco M.,Walker Bruce D.,Sette Alessandro,Heckerman David,Korber Bette T.,Brander Christian

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle

2. The Three-Dimensional Structure of Peptide-MHC Complexes

3. Emerging Principles for the Recognition of Peptide Antigens by MHC Class I Molecules

4. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

5. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides;Journal for ImmunoTherapy of Cancer;2024-04

2. Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses;Vaccines;2024-03-07

3. Computational immunogenomic approaches to predict response to cancer immunotherapies;Nature Reviews Clinical Oncology;2023-10-31

4. Identification of two novel T cell epitopes on the E2 protein of classical swine fever virus C-strain;Veterinary Microbiology;2023-09

5. Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma;Journal of Clinical Investigation;2022-01-18